Test

334 articles

Survivor Stories
April 13, 2020 • 3 Min

A Genetic Mutation Aids My Treatment

Malcolm Robertson carries the BRCA2 mutation, so when he was diagnosed with pancreatic cancer, platinum-based chemo was part of his treatment.

Survivor Stories
May 7, 2020 • 4 Min

Pancreatic Cancer Caught Early Because of My Vigilance

Beverly Leighton joined a screening study and underwent genetic testing because of her family history of pancreatic cancer.

Survivor Stories
November 16, 2020 • 4 Min

Practicing Gratitude Every Day

The best thing Chris Joseph ever did was change oncologists. His new doctor did genetic testing on Chris’s tumor, for better treatment.

Research
February 9, 2023 • 5 Min

PRECEDE Trial Sets Survival Rate Goal

Dr. Raymond Wadlow explains how earlier detection of high-risk people is key the PRECEDE trial’s goal to increase pancreatic cancer survival rates.

Research
August 27, 2019 • 5 Min

Platinum-Based Therapy Can Significantly Improve Survival for Some Pancreatic Cancer Patients

Dr. Michael Pishvaian explains how platinum-based therapy can improve the survival of pancreatic cancer patients with a specific mutation.

Research
September 3, 2020 • 6 Min

The Future of Pancreatic Cancer Treatment

Dr. Anil Rustgi discusses the latest developments in pancreatic cancer treatment and the direction of current research in early detection.

Research
January 12, 2022 • 5 Min

New Study Aims to Reduce Recurrence Risk for Select Patients

Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.

Page
January 22, 2025 • 1 Min

Latest Research

Research
July 24, 2024 • 2 Min

Testing a New Chemo and RNA Therapy Combination

Researchers are testing a new drug that binds to messenger RNA in combination with mFOLFIRINOX chemotherapy.

Research
November 28, 2016 • 2 Min

Testing the Effectiveness of Radiation and Standard Treatment

A clinical trial compares FOLFIRINOX plus stereotactic body radiation therapy (SBRT) with just FOLFIRINOX for pancreatic cancer that has spread locally.

Research
January 2, 2017 • 2 Min

Testing Targeted Immunotherapy Against Pancreatic Cancer

Targeted immunotherapy is the focus of a clinical trial that tests the drug ibrutinib, approved for leukemia treatment, against pancreatic cancer.

Research
February 9, 2017 • 2 Min

Testing Standard Treatment Plus an Antibody to Shrink Pancreatic Tumors

Researchers are testing whether adding a monoclonal antibody to standard chemotherapy will make locally advanced pancreatic cancer qualify for surgery.

Research
July 11, 2017 • 2 Min

Testing the Safety of a New Chemotherapy and Radiation Combination

A clinical trial tests the effectiveness of adding PEGPH20 to standard chemotherapy and radiation in patients with locally advanced pancreatic cancer.

Research
June 13, 2018 • 2 Min

Testing the Effectiveness of Immunotherapy Added to a New Drug Combination

Researchers are testing a drug combination that adds immunotherapy to standard drugs used to treat pancreatic cancer and an antimalarial drug.

Research
March 11, 2022 • 2 Min

Testing an Approved Drug for a Specific Mutation

Researchers are testing a drug combination for melanoma in pancreatic cancer patients with a BRAF genetic mutation.